Skip to content

Tompkins Financial

US · TMP #3024 by market cap Listed 1970
94.90 -1.16 -1.21%
Periodic snapshot; not a real-time feed. · 2026-11-20 16:15

Recent news

  • Rating change
    KBW Maintains Tompkins Financial(TMP.US) With Buy Rating, Maintains Target Price $78
    \u5e02\u573a\u8d44\u8baf · 2025/7/28
  • Rating change
    KBW Maintains Tompkins Financial(TMP.US) With Buy Rating, Raises Target Price to $87
    \u5e02\u573a\u8d44\u8baf · 2026/2/4
  • Rating change
    Piper Sandler Upgrades Tompkins Financial(TMP.US) to Buy Rating, Raises Target Price to $74
    \u5e02\u573a\u8d44\u8baf · 2025/12/3
  • Company notice
    Sosei Group: Our partner Tempero Bio has received approval from FDA for TMP-301 clinical trials for alcohol and other substance use disorders.
    JPX · 2023/1/5
  • Company notice
    Sosei Group: Sosei Notes Tempero Bio has Received FDA Clearance to Advance Clinical Development of TMP-301 for Treatment of Alcohol and Substance Use Disorders
    JPX · 2023/1/5
  • Rating change
    KBW Maintains Tompkins Financial(TMP.US) With Buy Rating, Raises Target Price to $83
    \u5e02\u573a\u8d44\u8baf · 2025/2/3
  • Rating change
    KBW Maintains Tompkins Financial(TMP.US) With Buy Rating, Maintains Target Price $83
    \u5e02\u573a\u8d44\u8baf · 2025/4/29
  • Earnings Flash (TMP) Tompkins Financial Corporation Reports Q2 Revenue $87.1M, Vs. FactSet Est of $86.9M
    MT Newswires · 2026/7/24
  • Rating change
    KBW Maintains Tompkins Financial(TMP.US) With Buy Rating, Maintains Target Price $80
    \u5e02\u573a\u8d44\u8baf · 2025/11/4
  • Company notice
    Maoshuo Power: Announcement on Passing UL WTDP and UL CB TMP Laboratory Accreditation
    SZSI · 2013/7/22
  • Company notice
    Nxera Pharma: Our partner Tempero Bio has begun phase 2 testing of TMP-301 targeting alcoholism
    JPX · 2025/3/25
  • Rating change
    Piper Sandler Maintains Tompkins Financial(TMP.US) With Hold Rating, Raises Target Price to $87
    \u5e02\u573a\u8d44\u8baf · 2026/4/28
  • Piper Sandler Maintains Tompkins Financial(TMP.US) With Hold Rating, Raises Target Price to $104
    \u5e02\u573a\u8d44\u8baf · 2026/8/3
  • Rating change
    KBW Maintains Tompkins Financial(TMP.US) With Buy Rating, Raises Target Price to $90
    \u5e02\u573a\u8d44\u8baf · 2026/4/28
  • Earnings Flash (TMP) Tompkins Financial Posts Q2 EPS $2.04, Vs. FactSet Est of $1.82
    MT Newswires · 2026/7/24
  • Company notice
    Nxera Pharma: Nxera Pharma’s Partner Tempero Bio Initiates Phase 2 Trial with TMP-301 for Alcohol Use Disorder
    JPX · 2025/3/25
  • Rating change
    KBW Maintains Tompkins Financial(TMP.US) With Buy Rating, Cuts Target Price to $78
    \u5e02\u573a\u8d44\u8baf · 2025/5/2
  • Rating change
    Piper Sandler Maintains Tompkins Financial(TMP.US) With Hold Rating, Cuts Target Price to $67
    \u5e02\u573a\u8d44\u8baf · 2025/5/1
  • KBW Maintains Tompkins Financial(TMP.US) With Buy Rating, Raises Target Price to $105
    \u5e02\u573a\u8d44\u8baf · 2026/7/27
  • KBW Maintains Tompkins Financial(TMP.US) With Buy Rating, Raises Target Price to $107
    \u5e02\u573a\u8d44\u8baf · 2026/10/26
  • Baichuan Co., Ltd. (002455.SZ): TMP products are primarily used in UV-curable coatings, synthetic lubricants, plasticizers, surfactants, and other applications.
    Gelonghui Finance · 2026/7/3
  • Rating change
    KBW Initiates Tompkins Financial(TMP.US) With Buy Rating, Announces Target Price $68
    \u5e02\u573a\u8d44\u8baf · 2024/10/2
  • Rating change
    Piper Sandler Initiates Tompkins Financial(TMP.US) With Hold Rating, Announces Target Price $70
    \u5e02\u573a\u8d44\u8baf · 2024/12/21
  • Rating change
    Keefe, Bruyette & Woods: Reiterates Tompkins Finl (TMP.US) rating, adjusted from market to market unanimous rating, target price adjusted from $55.00 to $50.00.
    Zhitong Finance · 2024/5/3
  • Baichuan Co., Ltd. (002455.SZ): The company's TMP capacity is 70,000 tons per year.
    Gelonghui Finance · 2026/6/15

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 16:15:00 · For reference only, not investment advice and not tailored to your situation.

Tompkins Financial discussion 0 comments

Add a comment